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Effect of hypoxia on proximal tubules isolated from nitric oxide
synthase knockout mice. Nitric oxide (NO) has been shown to be a
mediator of hypoxic injury in rat renal proximal tubules (PT). However,
the role of NO in hypoxic injury to mouse PT has not been examined. The
aim of the present study was to determine the effect of knockout of nitric
oxide synthase (NOS) isoforms on hypoxic injury in mouse PT. Mouse PTs
were isolated by collagenase digestion and Percoll centrifugation. The
nonselective NOS inhibitor, N-nitro-L-arginine methyl ester (L-NAME,
10 mM), but not its inactive stereoisomer D-NAME, protected against
hypoxic injury as assessed by LDH release. Carboxy-imidazolineoxyl
N-oxide (carboxy-PTIO, 100 mM), a stable NO scavenger, also afforded
cytoprotection against hypoxic injury. To determine the role of the
different NOS isoforms in the hypoxic injury, we examined the effect of
hypoxia on PT isolated from knockout mice in which either the inducible
NOS (iNOS), endothelial NOS (eNOS) or neuronal NOS (nNOS) gene
was lacking. PT isolated from iNOS knockout mice were resistant to
hypoxic injury compared to wild-type controls. In contrast, PT isolated
from both nNOS and eNOS knockout mice were not protected against
hypoxic injury. In conclusion, the present study demonstrates that NO is a
mediator of hypoxic PT injury in the mouse and that knockout of the iNOS
gene is cytoprotective against this hypoxic PT injury.
Nitric oxide (NO) is a messenger molecule mediating diverse
functions including vasodilation, neurotransmission, antimicro-
bial, antitumoricidal and immunological activities [1]. The forma-
tion of NO from L-arginine in mammalian cells is catalyzed by a
family of isoenzymes, called NO synthases (NOS) [2]. Thus far,
three distinct NOS isoforms have been isolated, purified and
cloned from neuronal tissue (nNOS), endothelial cells (eNOS)
and macrophage/vascular smooth muscle cells (macNOS/vs-
mNOS) [2–5].
All three isoforms of NOS are expressed in the kidney. The
macula densa is the principal site of nNOS gene expression in the
rat kidney [6]; this isoform has also been observed to a lesser
degree in collecting duct segments of the nephron, glomeruli and
renal vasculature [7]. nNOS has also been detected by Northern
analysis in cultured human kidney cortical epithelial cells grown
under conditions selective for cells with characteristics of proximal
tubular cells [8]. In the rat, eNOS mRNA has been detected by
reverse transcription-polymerase chain reaction (RT-PCR) in
both the renal vasculature and glomerulus as well as in several
nephron segments including the PT [9]. In the mouse, eNOS
protein was detectable by Western blot in whole kidney extracts,
and by immunohistochemical analysis eNOS was shown to be
localized in the PT [10]. Both RT-PCR and in situ hybridization
studies have demonstrated that iNOS mRNA is tonically and
differentially expressed along the rat nephron [11–13]. Induction
of iNOS by cytokines has been observed in primary cultures of rat
PT [14] and Mayeux et al have measured increased NOS activity
induced by LPS in freshly isolated rat PT [15].
In two recent studies, iNOS was reported to be induced during
renal ischemia/reperfusion in rats and mice [16, 17]. In the studies
of Noiri et al, treatment of the rats with antisense oligonucleotides
to iNOS prevented both the induction of iNOS measured in whole
kidney protein extracts and the increase in nitrite produced by
isolated PT [16]. This antisense treatment resulted in functional
protection assessed by blood urea nitrogen (BUN) and serum
creatinine. In studies by Chiao et al, prevention of iNOS induction
by alpha-melanocyte-stimulating hormone during ischemia/reper-
fusion was also associated with functional protection [17]. In that
study, iNOS protein was shown to be enriched during ischemia in
the outer medulla, which is the major site of histological damage
in this model of ischemic acute renal failure and is comprised
largely of PT.
We have previously examined freshly isolated renal PT from the
rat and have shown that NO is an important mediator of
hypoxia-induced PT injury in this in vitro model, which allows us
to examine effects of hypoxia on PT independent of potentially
influencing factors from other nephron segments or the vascula-
ture [18]. The present study was designed to examine whether NO
is also involved in hypoxic injury to mouse PT. In addition, we also
sought to determine which isoform is responsible for the hypoxic
injury observed in PT. We therefore examined the response to
hypoxia of PT isolated from knockout mice that lack the gene for
the specific NOS isoforms.
METHODS
Knockout mice
iNOS knockout mice (129SV/C57B6) [19] were generously
provided by Drs. John Mudgett (Merck Research Laboratories,
Rahway, NJ, USA) and Carl Nathan (Cornell University, New
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York, NY, USA). eNOS [20] and nNOS knockout mice (129SV/
C57B6) [21, 22] were kind gifts from Dr. Paul Huang (Harvard
Medical School, Boston, MA, USA). The genotype of each of
these knockout mice has been characterized previously by these
investigators [19–21].
Mouse PT isolation and hypoxia
Mouse PT were freshly isolated by the methods previously
described by this laboratory for rats with slight modification [23].
Male 129SV (Jackson Laboratories, Bar Harbor, ME, USA)
weighing 20 to 25 g were used as wild-type controls. Kidneys were
removed and the renal cortices were dissected, minced and
digested in oxygenated Solution A (in mM: NaCl 112, NaHCO3 18,
KCl 5, CaCl2 1.6, NaH2PO4 2.0, MgSO4 1.2, glucose 5, Hepes 2.5,
mannitol 10, glutamine 1, sodium butyrate 1, alanine 2 and
sodium lactate 1, buffered to pH 7.4), plus 40 mg of collagenase
type IV and 10 mg of hyaluronidase at 37°C under 95%O2/5%
CO2 in a shaking water bath for 30 minutes. The digested tissue
was then washed and suspended in 45% isotonic percoll and
centrifuged at 15,000 g for 10 minutes to separate PT. Proximal
tubules were washed 3 times with Solution A and collected in cold
oxygenated Solution B containing (in mM): NaCl 106, NaHCO3
18, KCl 5, CaCl2 1, NaH2PO4 2, MgSO4 1, glucose 5, Hepes 2.5,
glutamine 2, sodium butyrate 10, alanine 2 and sodium lactate 4
buffered to pH 7.1. The PT suspension was equilibrated 10
minutes at 37°C. To create hypoxia, PT were placed in siliconized
Ehrlenmeyer flasks and superfused with 95% N2/5% CO2 at a rate
of 3 liter/min for 15 minutes. When used, NOS inhibitors (N-
nitro-L-arginine methyl ester, L-NAME, 10 mM, D-NAME, 10
mM or carboxy-imidazolineoxyl N-oxide, carboxy-PTIO, 100 mM,
Alexis Corporation, San Diego, CA, USA) were added to the PT
suspension 10 minutes prior to hypoxia. In the knockout mouse
experiments, PT were isolated from wild-type and knockout mice
in parallel and exposed to either normoxia or hypoxia in an
identical manner. At the end of the hypoxic period, 1 ml of tubular
suspension was sampled for measurement of lactate dehydroge-
nase (LDH) release.
Lactate dehydrogenase measurement
LDH release was measured to evaluate cell damage as previ-
ously described [23, 24]. The percentage LDH released from
tubules was calculated by determining the ratio of LDH in the
supernatant compared to that in the lysed tubule pellet plus the
supernatant.
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was extracted from the aorta of wild-type and iNOS
knockout mice treated with either lipopolysaccharide (LPS; 20
mg/kg, i.p. for 8 hr; Sigma, St. Louis, MO, USA) or vehicle
(normal saline) using TRIZOL Reagent (Life Technologies).
iNOS was detected by RT-PCR using the RNA GeneAmp kit
(Perkin-Elmer Cetus, Norwalk, CT, USA). Briefly, 1 mg of total
RNA was reverse transcribed using murine leukemia virus reverse
transcriptase and random hexamers. The resulting cDNA was
amplified using 12.5 mM of each primer in a final volume of 40 ml.
Primers used for amplification were forward, 59-GCA TGG ACC
AGT ATA AGG CAA GCA-39, and reverse, 59-GCT TCT GGT
CGA TGT CAT GAG CAA-39 designed to yield a 222-bp
fragment [14]. PCR amplification was performed according to the
following schedule: denaturation, annealing and elongation at
94°C, 58°C, and 72°C, respectively, for three minutes each for 35
cycles, followed by an extension at 72°C for seven minutes
(Thermocycler; Perkin-Elmer Cetus). MgCl2 concentration was
2.5 mM/sample. The PCR product was separated on a 1.2%
agarose gel containing ethidium bromide, and DNA bands were
visualized with an ultraviolet transilluminator. RT-PCR of
GADPH showed equivalent amounts of RNA in each lane.
Statistical analysis
Values are expressed as mean 6 SE. Multiple group compari-
sons were done using the analysis of variance (ANOVA) with
post-test according to Newman-Keuls. A P value of less than 0.05
was considered statistically significant.
RESULTS
Hypoxia-induced tubular injury
Freshly isolated mouse PTs were exposed to hypoxia for various
periods of time. As shown in Figure 1, hypoxia resulted in cell
membrane damage in a time dependent manner, as assessed by
LDH release. A significant increase of LDH release occurred
after 15 minutes of hypoxia and lasted up to 30 minutes as
compared to normoxic controls.
Role of nitric oxide in the hypoxic-induced tubular injury
To examine the roles of NO in hypoxic PT injury, freshly
isolated wild-type mouse PT were incubated with either a nonse-
lective NOS inhibitor, L-NAME (10 mM) or a stable NO scaven-
ger, carboxy-PTIO (100 mM) prior to the onset of hypoxia.
L-NAME, but not its inactive stereoisomer D-NAME, protected
against hypoxic injury as assessed by LDH release. LDH release
was 12% in normoxia, 44% after 15 minutes of hypoxia (P , 0.001
vs. normoxia, N 5 5), 25% in hypoxia 1 L-NAME (P , 0.001 vs.
hypoxia, N 5 5; Fig. 2). Hypoxia 1 D-NAME (10 mM) did not
demonstrate any protection as compared to normoxic controls
(39% vs. 44%, NS, N 5 5). Further support for the involvement of
NO is the demonstration that carboxy-PTIO also afforded cyto-
protection against hypoxic cell membrane damage at 15 minutes
of hypoxia. LDH release was significantly less with hypoxia versus
hypoxia 1 PTIO (37% vs. 27%, P , 0.05, N 5 7).
Fig. 1. Freshly isolated mouse proximal tubules (PT) were exposed to
hypoxia for 5, 15 and 30 minutes. Cell membrane damage was assessed by
lactate dehydrogenase (LDH) release (N 5 3).
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Effects of hypoxia on tubular injury of knockout mice
As assessed by LDH release, PT isolated from iNOS knockout
mice were resistant to hypoxia-induced cell membrane damage.
LDH release was 12% in wild-type1normoxia, 41% in wild-
type1hypoxia, P , 0.01; 12% in iNOS knockout mice1normoxia
and 18% in iNOS knockout mice1hypoxia, P 5 NS, N 5 6 (Fig.
3). In contrast, PT isolated from both nNOS and eNOS knockout
mice were not protected against hypoxic injury. LDH release was
12% in wild-type1normoxia, 30% in wild-type1hypoxia, P ,
0.01; 13% in nNOS knockout mice1normoxia and 27% in nNOS
knockout mice1hypoxia, P , 0.01; 12% in eNOS
knockout1normoxia and 34% in eNOS knockout1hypoxia, P ,
0.01 (Figs. 4 and 5).
Determination of inducible nitric oxide synthase gene deletion
The mRNA and protein of NOS isoforms in all three knockout
mice have been previously examined to confirm the successful
deletion of the specific NOS genes [19–22]. However, to confirm
that there was no genetic modification due to either continuous
breeding or enviromental changes, we performed a RT-PCR
analysis of mouse aortic RNA to verify iNOS gene deletion in
iNOS knockout mice. RNA was obtained from control and LPS
stimulated wild type and iNOS knockout mice. As shown in Figure
6, a single PCR product that matched the predicted size of iNOS
(222 bp) was observed in wild-type but not in iNOS knockout
mice, indicating a slight basal expression in the wild-type mice.
LPS treatment substantially increased iNOS message in the
wild-type mice. In contrast, iNOS message was undetectable in
aorta from iNOS knockout mice and LPS treatment had no effect.
DISCUSSION
We have previously shown NO to be an important mediator of
rat hypoxic PT damage [18]. The present study demonstrates that
NO is also a mediator of hypoxic cell injury in isolated mouse PT.
The nonselective NOS inhibitor, L-NAME, was shown to be
Fig. 2. The nonselective nitric oxide synthase (NOS) inhibitor, N-nitro-
L-arginine methyl ester (L-NAME, 10 mM), but not its inactive stereoiso-
mer D-NAME (10 mM), protected against hypoxic injury as assessed by
lactate dehydrogenase (LDH) release in mouse PT (N 5 4).
Fig. 3. Proximal tubules (PT) were freshly isolated in parallel from
inducible nitric oxide synthase (iNOS) knockout mice and wild-type
controls, and exposed to 15 minutes of hypoxia in the same experiments
(N 5 6). PT from the knockout mice were resistant to hypoxia-induced cell
membrane damage as measured by lactate dehydrogenase (LDH) release.
In contrast, PT from wild-type controls showed extensive cell membrane
damage.
Fig. 4. Proximal tubules (PT) were freshly isolated in parallel from
endothelial nitric oxide synthase (eNOS) knockout mice and wild-type
controls, and exposed to 15 minutes of hypoxia in the same experiments
(N 5 4). In contrast to iNOS knockout mice (Fig. 3), PT from eNOS
knockout mice demonstrated no protection against hypoxic cell membrane
damage compared to wild-type controls (LDH release of 35%).
Fig. 5. Proximal tubules (PT) were freshly isolated in parallel from
neuronal nitric oxide synthase (nNOS) knockout mice and wild-type
controls, and exposed to 15 minutes of hypoxia in the same experiments
(N 5 4). In contrast to iNOS knockout mice (Fig. 3), PT from nNOS
knockout mice demonstrated no protection against hypoxic cell membrane
damage compared to wild-type controls.
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protective against hypoxia-induced damage, whereas its inactive
stereoisomer, D-NAME, had no effect. In addition, protection
was also afforded by treatment of the PT with an NO scavenger,
carboxy-PTIO.
To determine the role of the different NOS isoforms during
hypoxic PT injury, we studied the effect of hypoxia on PT isolated
from mice lacking either the nNOS, eNOS or iNOS gene. The
results demonstrated that hypoxia produced significant membrane
damage in PT from both nNOS and eNOS knockout mice, to a
similar degree to that observed in wild type control mice. In
contrast, PT isolated from iNOS knockout mice were highly
resistant to hypoxia.
The mechanism of the resistance to hypoxia in iNOS knockout
mice is unknown, however, there are various possibilities. Because
of the short exposure of the PT to hypoxia in these experiments
(15 min), and the observation that iNOS induction most likely
takes much longer, it is possible that iNOS was already present in
the PT. The basal amount of iNOS may be in such a low
abundance in PT that it is undetectable using presently available
antibodies. In this regard, studies of Mohaupt et al [12] and Ahn
et al [11] indicate that iNOS mRNA is tonically expressed in the
PT, and these investigators have speculated that basal NO pro-
duction by iNOS may be important in normal renal physiology.
Specifically, these investigators demonstrated two isoforms of
iNOS to be expressed basally in the rat kidney. One form was
highly homologous to the macrophage iNOS (macNOS) and
another isoform distinct from the macNOS was found to be
identical to the vascular smooth muscle iNOS (vsmNOS). The
isoform found to be expressed basally in the PT was the macNOS.
In in vivo studies, by targeting macNOS with specific antisense
nucleotides, Noiri et al were able to dramatically attenuate the
functional and histological changes induced in a model of renal
ischemia in the rat [16]. Interestingly, antisense to the vsmNOS
worsened the injury in this ischemic model. Our current findings
are supportive of those of Noiri et al and suggest that iNOS
expressed by PT cells is directly damaging to these cells during
hypoxia. On the other hand, one cannot rule out the possibility
that other factors are involved in the resistance of the iNOS
knockout PT to hypoxia.
Recent studies with recombinant iNOS protein indicate that
iNOS is twice as active in the presence of Ca21 as in its absence
[25]. Other studies have also demonstrated the Ca21 dependency
of iNOS activity [15, 26, 27]. Thus, it is possible that iNOS activity
during hypoxia is to some extent Ca21-dependent. In this regard
we have demonstrated that 10 minutes of hypoxia induces a
prelethal increase in free cytosolic Ca21 in proximal tubules [28].
It is known that in vivo S3 proximal tubules are more poised for
hypoxic damage than S1 and S2 tubules. Chiao et al could only
demonstrate induction of iNOS protein in the outer medulla of
the kidney (site of S3 proximal tubules) and not in the cortex (site
of S1 and S2 proximal tubules) [17]. However, Noiri et al detected
NO by measurement of nitrite production in cortical tubules [16].
Our results are in agreement with the latter study as our proximal
tubule preparation consists of cortical tubules.
Absence of the iNOS gene afforded greater protection against
hypoxic injury in the wild-type mice PT than did either L-NAME
or the stable NO scavenger carboxy-PTIO. A possible reason for
this is that NOS inhibitors and NO scavengers may not optimally
block or scavenge NO. They can also have poor membrane
penetration and lack of selectivity for a particular isoform. For
these reasons we believe that the results in the knockout mice are
more important than the L-NAME and carboxy-PTIO studies.
As NO is formed from L-arginine and molecular oxygen, it is
possible that hypoxia could substrate limit NO production. How-
ever, it has been demonstrated that although 3H-citrulline pro-
duction is reduced at a pO2 of 28 mm Hg compared to 130 mm
Hg, there is still significant 3H-citrulline production at the lower
pO2 [29]. Thus, even this lesser amount of NO, formed in the
Fig. 6. RT-PCR for inducible nitric oxide
synthase (iNOS) mRNA was performed in
extracts from aorta of both wild-type and iNOS
knockout mice treated with lipopolysaccharide
(LPS) or vehicle (saline). Lane 1 shows
mesenteric artery isolated from septic rats
which was used as a positive control. Lanes 2
and 3 show the absence of iNOS mRNA from
aortae of iNOS knockout mice treated with
either vehicle (lane 2) or LPS (lane 3). Lane 4
shows that iNOS mRNA is basally present in
the aorta of wild-type mice. Lane 5 shows the
induction of iNOS mRNA in the aorta of wild-
type mice treated with LPS.
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presence of superoxide generated during hypoxia in our model
(PO2 of about 30 to 50 mm Hg), would be enough to form the
injurious radical, peroxynitrite.
In conclusion, the present study demonstrates that NO is a
mediator of hypoxic injury in mouse PT and that PT isolated from
iNOS knockout mice are resistant to this hypoxic injury.
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